{"name":"ViewRay","slug":"viewray","ticker":"VRAY","exchange":"NASDAQ (Delisted)","domain":"viewray.com","description":"ViewRay is a medical technology company specializing in radiation oncology. The company's flagship product is the MRIdian system, a magnetic resonance-guided radiation therapy platform. ViewRay's technology enables precise and personalized cancer treatment. The company is positioned as a leader in the radiation oncology market.","hq":"Denver, CO","founded":0,"employees":"","ceo":"Scott Drake (pre-bankruptcy)","sector":"Radiation Oncology MedTech","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"$0 (Bankrupt)","metrics":{"revenue":95000000,"revenueGrowth":53.1,"grossMargin":0,"rdSpend":32431000,"netIncome":-107330000,"cash":271397000,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2017"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[{"date":"2024-02-28","type":"earnings","headline":"ViewRay Reports Fourth Quarter and Full Year 2023 Financial Results","summary":"ViewRay reported revenue of $44.4 million for the fourth quarter of 2023, a 14% increase from the same period in 2022.","drugName":"","sentiment":"neutral"},{"date":"2023-09-14","type":"deal","headline":"ViewRay Announces Collaboration with Elekta to Enhance Radiation Therapy Treatments","summary":"ViewRay and Elekta have entered into a collaboration to integrate their technologies and enhance radiation therapy treatments.","drugName":"","sentiment":"positive"},{"date":"2023-06-15","type":"regulatory","headline":"ViewRay Receives FDA Clearance for MRIdian Linac System","summary":"ViewRay has received FDA clearance for its MRIdian Linac system, a next-generation radiation therapy platform.","drugName":"","sentiment":"positive"}],"realNews":[{"date":"2023-09-07","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: 8-K","headline":"SEC 8-K: 8-K","sentiment":"neutral"},{"date":"2023-08-03","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: 8-K","headline":"SEC 8-K: 8-K","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMihwJBVV95cUxOS213QTNZSzI1MEdEQ2h1SGVUVjlWckpkUWpFdmR1QUpoMXQ0LUlDRG4zanM4bk5Iclh1eFlEblpabVgxaWRyci12dEl2aWJWRnhkcktiM1l0cDdCZHVjc2Z0NGFENGJVa3JKUlRTbG01cC05WHZkLW5zUHYzUmdlS3VaZ1ItNXV1U3pLbm5wcmxGc2dSZnh5MFV6U3czcldyWFROOEFjU0NOeXkzT2FZYlp4OWVtN2JkMnkxMzIzZmNYbWwzRF9sUll4QXZZcF9PLXBRY0cwVzBPSzZ5dFl0Und4NEQ3a1JTOTN2RDdIVmNpdjU3Sk9STWRMYjFzT0NSaG5VZXFyOA?oc=5","date":"2023-07-21","type":"pipeline","source":"PR Newswire","summary":"ViewRay® Announces Commencement of Nasdaq Delisting Proceedings: Common Stock Expected to Begin Trading on the OTC Markets - PR Newswire","headline":"ViewRay® Announces Commencement of Nasdaq Delisting Proceedings: Common Stock Expected to Begin Trading on the OTC Marke","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi0wFBVV95cUxOaWxfbi1MZS1Ncm1kUURrcTB5RGdzQ2pQV2psRUE3Q0FXdFo3QUhabTNpblNTVnFhMVA4a0NHUjJ2NmFmNFlYaWJIT2JFWFBLQXMybW9xMXhNNGIzNTUzQjJlb0lBUVBVVXdaaTNkNVJnNVo4MW15VzRIQkJYSW8yQ3poTXBtSlhIZDAwODhXMDRPdFNmU3pwdzdlRm5DQk5UQ0Rlc0FJckxPOTJWNjNIaXgxUThkT25sdi1Ta3c4dTEzX0pNbDFIUGtENFFKWUxScGdV?oc=5","date":"2023-01-05","type":"deal","source":"PR Newswire","summary":"Chindex Medical Acquires 10 ViewRay MRIdian® Systems for Advanced Cancer Treatment - PR Newswire","headline":"Chindex Medical Acquires 10 ViewRay MRIdian® Systems for Advanced Cancer Treatment","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi_gFBVV95cUxObEI0UFc3VkJGZTI1SzZ4eGhtaXd4MEtQbk9iZEQ5al9heEJvWG5nTXowZjlEU21yd2pvSmlFTVBmVlFWMWdwLVEzWm1YUEkxMy1GQi1IYjljT0NLX19yMWhRZThTazI3VlJCa0pYQXhPU0s5ZGtLUjRlV1IwSW9wOFAzRTNjbzd2Y1ZVdDg3OG45bVNHUlVFUjFEUy1yS0Jrb2xoaGE2aURXTkpFVVVnbFN5SlBlTjgxRThHTDg2dC0wWFdvNXFPRk9SZWZzMGhsb1A4OFZUeWtBMk5wZmFaZ2xKcVpYQjJEZG1OUU5QSE5IdFJMdmladGRWcGlKZw?oc=5","date":"2023-01-05","type":"pipeline","source":"PR Newswire","summary":"University Hospitals in Cleveland Enters into Master Purchase Agreement with ViewRay for Multiple MRIdian® Systems - PR Newswire","headline":"University Hospitals in Cleveland Enters into Master Purchase Agreement with ViewRay for Multiple MRIdian® Systems","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiugFBVV95cUxNNUpZQkNmYkNDdnNGdnRIUnpOekc5c05DcW5ZZEcxVUJmYWtXMGVjVjlZOExBQUdMNGJNVFUwT2h1dFNtNW9XQURlZW8wUmNmSDhxMHhxSWYyZjA5cTJQXzBhZnctSlRZNW9DZFNiX19KUklnc2p6QVU1U1VYV2dTTV9KbFpkREI5aU94Zm5zWjZ5NjdFaWU4ektVdm90ckZ1R1VyVXBjdGliVVhmTG9STWZuX0ZZMTlNb0E?oc=5","date":"2020-12-21","type":"pipeline","source":"PR Newswire","summary":"Eindhoven's Catharina Hospital Purchases ViewRay's MRIdian Linac - PR Newswire","headline":"Eindhoven's Catharina Hospital Purchases ViewRay's MRIdian Linac","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":3,"visitCount":1,"keyCompetitors":["Varian Medical Systems","Accuray Incorporated","Elekta AB"],"therapeuticFocus":["Radiation Oncology"],"financials":{"source":"sec_edgar","revenue":34042000,"revenuePeriod":"2017-12-31","revenueHistory":[{"value":34042000,"period":"2017-12-31"},{"value":22237000,"period":"2016-12-31"},{"value":22237000,"period":"2016-12-31"},{"value":10390000,"period":"2015-12-31"},{"value":10390000,"period":"2015-12-31"}],"grossProfit":null,"grossProfitHistory":[],"rdSpend":32431000,"rdSpendHistory":[],"sgaSpend":null,"operatingIncome":null,"operatingIncomeHistory":[],"netIncome":-107330000,"netIncomeHistory":[],"eps":null,"epsHistory":[],"cash":null,"cashHistory":[],"totalAssets":271397000,"totalLiabilities":null,"totalDebt":null,"equity":null,"operatingCashflow":null,"operatingCashflowHistory":[],"capex":null,"capexHistory":[],"freeCashflow":null,"dividendsPaid":null,"buybacks":null,"employees":null,"segmentRevenue":[],"geographicRevenue":[],"ciks":null,"lastFiledAt":null},"yahoo":null}